Do general practitioners use prostate-specific antigen as a screening test for early prostate cancer?

Medical Journal of Australia

Volumn 169, Issue 1, 1998, Pages 29-31

  Ward, Jeanette E ^a   Gupta, Leena ^a,b   Taylor, Nicholas J ^c  

^a Health Outcomes Unit   (Australia)

^b CENTRAL SYDNEY AREA HEALTH SERVICE   (Australia)

^c Macquarie Pathology Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AUSTRALIA; CANCER SCREENING; GENERAL PRACTITIONER; MORBIDITY; PRACTICE GUIDELINE; PROSTATE CANCER; QUESTIONNAIRE; SCREENING TEST;

EID: 0032490589     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb141474.x     Document Type: Article

References (28)

1. Parkes AJ, Killer GT. Prostate-specific antigen - is it already being used as a screening test? [letter]. Med J Aust 1994; 161: 722-723.
2. Sladden MJ, Dickinson JA. General practitioners' attitudes to screening for prostate and testicular cancers. Med J Aust 1995; 162: 410-413.
3. Ward J, Young J, Sladden M. Australian general practitioners' views and use of tests to detect early prostate cancer. Aust N Z J Public Health 1998. In press.
4. Kelberry R Knuckey J, Manolson P, Wright G. Screening for prostate cancer: WA GPs' attitudes and knowledge. Department of Public Health, UWA: unpublished report, 1996.
5. Kaye KW. Prostate cancer: enthusiasm for screening. Med J Aust 1995; 162: 540-541.
6. Rogers JH, Taylor JS. Prostate cancer: enthusiasm for screening [letter]. Med J Aust 1995; 163: 160.
7. Hirst G, Ward J, Del Mar C. Prostate cancer screening: the case against. Med J Aust 1996; 164: 285-288.
8. Australian Health Technology Advisory Committee. Prostate cancer screening. Canberra: AGPS, 1996.
9. National Health and Medical Research Council. Clinical practice guidelines. The management of uncomplicated lower urinary tract symptoms in men. Canberra: AGPS, 1996.
10. Catalona W, Richie J, Ahmann F, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283-1290.
11. Rietbergen J, Kranse R, Boeken Kruger A, et al. Additional value of the AUA7 symptom score in prostate cancer (PC) detection. J Urol 1997; 157: 467.
12. Coley C, Barry M, Fleming C, Mulley A. Early detection of prostate cancer Part I: prior probability and effectiveness of tests. Ann Intern Med 1997; 126: 394-406.
13. Threlfall TJ, English DR, Rouse IL. Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996. Med J Aust 1998; 169: 21-24.
14. Commonwealth Department of Health and Family Services. General practice in Australia: supplementary tables 1997. Canberra: General Practice Branch, 1997; 19. (Publication No 1838.)
15. SAS for Windows [computer program]. Version 6. Cary, North Carolina: SAS Institute, 1990.
16. Ward JE, Hughes AM, Hirst GHL, Winchester L. Men's estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 1997; 167: 250-253.
17. Commonwealth Department of Human Services and Health. Better health outcomes for Australians: national goals, targets and strategies for better health outcomes into the next century. Canberra: AGPS, 1994.
18. Cancer Expert Working Group. Cancer control NSW goals and targets. Sydney: NSW Health, 1995; 68-70.
19. 1996/97 Performance Agreement between the Director-General of NSW Health and the Central Sydney Area Health Service. 26 August 1996.
20. Freemantle N, Harvey EL, Wolf F, et al. Printed educational materials to improve the behaviour of health care professionals and patient outcomes. In: Bero L, Grilli R, Grimshaw J, Oxman A, editors. Collaboration on effective professional practice module of the Cochrane database of systematic reviews, 3 March 1997. The Cochrane Library [database on CD-ROM]. Oxford: Update Software, 1997.
21. Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996; 156: 1333-1336.
22. Wolf A, Philbrick J, Schorling J. Predictors of interest in prostate-specific antigen screening and the impact of informed consent: what should we tell our patients? Am J Med 1997; 103: 308-314.
23. Flood A, Wennberg J, Nease R, et al. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med 1996; 11: 342-349.
24. Kaiser Permanente Health Plan. To screen or not to screen: that is the question. . Accessed 6 May 1998.
25. Chodak G. A patient's guide to screening for prostate cancer. . Accessed 6 May 1998.
26. Institute for Clinical Evaluative Sciences. Information about prostate cancer and the PSA test. . Accessed 22 May 1998.
27. Skelton N, Skelton W. Changing physician PSA ordering patterns through education. Arch Intern Med 1994; 154: 819-820.
28. Thompson R, McAfee T, Stuart M, et al. A review of clinical prevention services at Group Health Co-operative of Puget Sound. Am J Prev Med 1995; 11: 409-416.